Literature DB >> 1777846

Interleukin-6 is a centrally acting endogenous pyrogen in the rat.

N J Rothwell1, N J Busbridge, R A Lefeuvre, A J Hardwick, J Gauldie, S J Hopkins.   

Abstract

Intracerebroventricular (i.c.v.) injection of human recombinant interleukin-6 (IL-6; 20-100 ng) caused significant increases in colonic temperature and resting oxygen consumption (VO2) in conscious rats. These effects were prevented by pretreatment with a cyclooxygenase inhibitor (flurbiprofen, 1 mg/kg, i.p.) or a corticotrophin-releasing factor antagonist (alpha-helical CRF9-41, 25 micrograms, i.c.v.). Higher doses of IL-6 (i.c.v.) caused only small changes in VO2 and temperature, and very high doses given intravenously (i.v.) (4 micrograms/kg) were required to stimulate these parameters. Central injection of anti-rat IL-6 antibody inhibited the effects of interleukin-1 beta (i.c.v.) or endotoxin injection (i.p.) on colonic temperature and VO2 in conscious rats. These data indicate that IL-6 is an important endogenous pyrogen that acts within the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1777846     DOI: 10.1139/y91-219

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  15 in total

1.  Interleukin-6 mediates low-threshold mechanical allodynia induced by intrathecal HIV-1 envelope glycoprotein gp120.

Authors:  Diana K Schoeniger-Skinner; Annemarie Ledeboer; Matthew G Frank; Erin D Milligan; Stephen Poole; David Martin; Steven F Maier; Linda R Watkins
Journal:  Brain Behav Immun       Date:  2007-01-03       Impact factor: 7.217

2.  IL6 as a mediator of insulin resistance: fat or fiction?

Authors:  T L Allen; M A Febbraio
Journal:  Diabetologia       Date:  2009-12-10       Impact factor: 10.122

Review 3.  Annual review prize lecture cytokines - killers in the brain?

Authors:  N J Rothwell
Journal:  J Physiol       Date:  1999-01-01       Impact factor: 5.182

4.  Leptin actions on food intake and body temperature are mediated by IL-1.

Authors:  G N Luheshi; J D Gardner; D A Rushforth; A S Loudon; N J Rothwell
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

Review 5.  Physiological and pathological roles of interleukin-6 in the central nervous system.

Authors:  D L Gruol; T E Nelson
Journal:  Mol Neurobiol       Date:  1997-12       Impact factor: 5.590

Review 6.  Molecular mechanisms of actions of interleukin-6 on the brain, with special reference to serotonin and the hypothalamo-pituitary-adrenocortical axis.

Authors:  N Barkhudaryan; A J Dunn
Journal:  Neurochem Res       Date:  1999-09       Impact factor: 3.996

7.  A variant near the interleukin-6 gene is associated with fat mass in Caucasian men.

Authors:  N Andersson; L Strandberg; S Nilsson; S Adamovic; M K Karlsson; O Ljunggren; D Mellström; N E Lane; J M Zmuda; C Nielsen; E Orwoll; M Lorentzon; C Ohlsson; J-O Jansson
Journal:  Int J Obes (Lond)       Date:  2010-02-16       Impact factor: 5.095

8.  The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia.

Authors:  F Q Cunha; S Poole; B B Lorenzetti; S H Ferreira
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

9.  Effects of i.c.v. administration of interleukin-1 on sleep and body temperature of interleukin-6-deficient mice.

Authors:  M D Olivadoti; M R Opp
Journal:  Neuroscience       Date:  2008-02-19       Impact factor: 3.590

10.  Central nervous system administration of interleukin-6 produces splenic sympathoexcitation.

Authors:  Bryan G Helwig; Robin A Craig; Richard J Fels; Frank Blecha; Michael J Kenney
Journal:  Auton Neurosci       Date:  2008-06-10       Impact factor: 3.145

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.